Protein & Cell >

2021 , Vol. 12 >Issue 10: 818 - 823

DOI: https://doi.org/10.1007/s13238-021-00840-z

LETTER

Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine

  • Xingdong Zhou 1,3 ,
  • Hui Wang 2 ,
  • Qun Ji 3 ,
  • Mingjuan Du 3 ,
  • Yuexia Liang 1 ,
  • Huanhuan Li 1 ,
  • Fan Li 1 ,
  • Hang Shang 1 ,
  • Xiujuan Zhu 2 ,
  • Wei Wang 3 ,
  • Lichun Jiang 3 ,
  • Alexey V. Stepanov 4 ,
  • Tianyu Ma 1 ,
  • Nanxin Gong 1 ,
  • Xiaodong Jia 5 ,
  • Alexander G. Gabibov 4 ,
  • Zhiyong Lou , 6 ,
  • Yinying Lu , 5 ,
  • Yu Guo , 1 ,
  • Hongkai Zhang , 1,3 ,
  • Xiaoming Yang , 2
Expand
  • 1. State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin 300071, China
  • 2. Beijing Institute of Biological Products Company Limited, Beijing 100176, China
  • 3. Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China
  • 4. M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 117997
  • 5. Comprehensive Liver Cancer Center, The 5th Medical Center of PLA General Hospital, Beijing 100039, China
  • 6. MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing 100084, China

Accepted date: 22 Mar 2021

Published date: 15 Oct 2021

Copyright

2021 The Author(s) 2021
Fold

Cite this article

Xingdong Zhou , Hui Wang , Qun Ji , Mingjuan Du , Yuexia Liang , Huanhuan Li , Fan Li , Hang Shang , Xiujuan Zhu , Wei Wang , Lichun Jiang , Alexey V. Stepanov , Tianyu Ma , Nanxin Gong , Xiaodong Jia , Alexander G. Gabibov , Zhiyong Lou , Yinying Lu , Yu Guo , Hongkai Zhang , Xiaoming Yang . Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine[J]. Protein & Cell, 2021 , 12(10) : 818 -823 . DOI: 10.1007/s13238-021-00840-z

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ (2020) Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 383:2427–2438

DOI

2
Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, Bangaru S, Torres JL, Okba NMA, Claireaux M, Kerster G (2020) Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369:643–650

DOI

3
Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C (2020) Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput Single-cell sequencing of convalescent patients’ B cells. Cell 182:73–84

DOI

4
Jones I, Roy P (2021) Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet. 397(10275):642–643

DOI

5
Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S (2020) Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584:115–119

DOI

6
Lerner RA (2006) Manufacturing immunity to disease in a test tube: the magic bullet realized. Angew Chem 45:8106–8125

DOI

7
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615

DOI

8
Rajan S, Kierny MR, Mercer A, Wu J, Tovchigrechko A, Wu H, Dall Acqua WF, Xiao X, Chowdhury PS (2018) Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies. Commun Biol 1:5

DOI

9
von Boehmer L, Liu C, Ackerman S, Gitlin AD, Wang Q, Gazumyan A, Nussenzweig MC (2016) Sequencing and cloning of antigenspecific antibodies from mouse memory B cells. Nat Protoc 11:1908–1923

DOI

10
Wang B, DeKosky BJ, Timm MR, Lee J, Normandin E, Misasi J, Kong R, McDaniel JR, Delidakis G, Leigh KE (2018) Functional interrogation and mining of natively paired human V (H):V(L) antibody repertoires. Nat Biotechnol 36:152–155

DOI

11
Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J (2020) Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 182:713–721.e719

DOI

12
Wang P, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS (2021) Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization. bioRxiv, 2021.2001.2025.428137.

13
Wen GP, He L, Tang ZM, Wang SL, Zhang X, Chen YZ, Lin X, Liu C, Chen JX, Ying D (2020) Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans. Nat Commun 11:3971

DOI

14
Wu S, Zhong G, Zhang J, Shuai L, Zhang Z, Wen Z, Wang B, Zhao Z, Song X, Chen Y (2020) A single dose of an adenovirusvectored vaccine provides protection against SARS-CoV-2 challenge. Nat Commun 11:4081

DOI

15
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z (2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 21:39–51

DOI

Options
Outlines

/

〈 〉